A detailed history of Trexquant Investment LP transactions in Annexon, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 313,093 shares of ANNX stock, worth $2.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
313,093
Holding current value
$2.2 Million
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.33 - $6.79 $1.36 Million - $2.13 Million
313,093 New
313,093 $1.53 Million
Q1 2023

May 15, 2023

BUY
$3.74 - $7.46 $170,188 - $339,467
45,505 New
45,505 $175,000
Q2 2022

Aug 11, 2022

SELL
$2.11 - $4.06 $66,184 - $127,350
-31,367 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$2.73 - $11.94 $13,576 - $59,377
-4,973 Reduced 13.68%
31,367 $86,000
Q4 2021

Feb 14, 2022

BUY
$11.49 - $22.0 $417,546 - $799,480
36,340 New
36,340 $418,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $335M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.